A practical buyer’s guide: 12 questions pharma and biotech companies should ask when evaluating AI-powered regulatory technology platforms.
An inside look at DnXT’s Compliance Monitoring Dashboard — 6 compliance agents, 8 daily checks, and how continuous monitoring catches problems before auditors do.
Why life sciences may need regulatory platforms designed for AI from the ground up — and the honest counter-arguments to that position.
A practical look at eCTD validation: 23 compliance rules, multi-region support, and how AI helps with preparation while deterministic rules handle the actual checking.
A look inside DnXT’s V5 workflow engine — 50+ endpoints, state machine architecture, and the preCheck pattern that lets AI agents look before they leap.
Electronic signatures in regulated environments require human attribution. Here’s why AI agents must be architecturally blocked from signing, not just told not to.
A balanced analysis of how Veeva, Kivo, DnXT, and generic AI platforms approach AI in regulatory publishing — strengths and limitations of each.
A technical breakdown of four-layer tenant isolation in DnXT’s regulatory platform, and why it matters when AI agents interact with regulated data.
A technical look at how DnXT’s audit trail infrastructure handles AI-initiated actions while maintaining 21 CFR Part 11 and ALCOA+ data integrity standards.
How the Model Context Protocol enables AI agents to interact with GxP compliance systems while maintaining regulatory guardrails and audit integrity.
